Clinical Trials Directory

Trials / Completed

CompletedNCT04997135

Clinical Evaluation of Therapeutic Meibomian Gland Expression

Status
Completed
Phase
Study type
Observational
Enrollment
16 (actual)
Sponsor
Johnson & Johnson Vision Care, Inc. · Industry
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

This will be a single centre pilot study to evaluate appearance of the Meibomian glands.

Conditions

Timeline

Start date
2021-08-15
Primary completion
2021-11-11
Completion
2021-11-11
First posted
2021-08-09
Last updated
2021-12-01

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT04997135. Inclusion in this directory is not an endorsement.

Clinical Evaluation of Therapeutic Meibomian Gland Expression (NCT04997135) · Clinical Trials Directory